The positivity offset theory of anhedonia in schizophrenia: evidence for a deficit in daily life using digital phenotyping
- PMID: 36722014
- PMCID: PMC10600929
- DOI: 10.1017/S0033291722003774
The positivity offset theory of anhedonia in schizophrenia: evidence for a deficit in daily life using digital phenotyping
Abstract
Background: Negative symptoms of schizophrenia have recently been proposed to result from a decoupling of (intact) hedonic experience and (diminished) approach behavior. The current study challenged this view by exploring the hypothesis that negative symptoms are driven by a specific type of emotional experience abnormality, a reduction in the positivity offset (i.e. the tendency to experience greater levels of positive relative to negative emotion in low-arousal contexts), which limits the production of approach behaviors in neutral environments.
Methods: Participants included outpatients with SZ (n = 44) and healthy controls (CN: n = 48) who completed one week of active (ecological momentary assessment surveys of emotional experience and symptoms) and passive (geolocation, accelerometry) digital phenotyping. Mathematical modeling approaches from Cacioppo's Evaluative Space Model were used to quantify the positivity offset in daily life. Negative symptoms were assessed via standard clinical ratings, as well as active (EMA surveys) and passive (geolocation, accelerometry) digital phenotyping measures.
Results: Results indicated that the positivity offset was reduced in SZ and associated with more severe anhedonia and avolition measured via clinical interviews and active and passive digital phenotyping.
Conclusions: These findings suggest that current conceptual models of negative symptoms, which assume hedonic normality, may need to be revised to account for reductions in the positivity offset and its connection to diminished motivated behavior. Findings identify key real-world contexts where negative symptoms could be targeted using psychosocial treatments.
Keywords: Ecological momentary assessment; emotional experience; hedonic capacity; negative symptoms; psychosis.
Conflict of interest statement
Dr Strauss is one of the original developers of the Brief Negative Symptom Scale (BNSS) and receives royalties and consultation fees from ProPhase LLC in connection with commercial use of the BNSS and other professional activities; these fees are donated to the Brain and Behavior Research Foundation. Dr Strauss has received honoraria and travel support from ProPhase LLC for training pharmaceutical company raters on the BNSS. In the past two years, Dr Strauss has consulted for and/or been on the speaker bureau for Minerva Neurosciences, Acadia, and Lundbeck pharmaceutical companies. All other authors have no conflicts to report.
Figures

References
-
- American Psychiatric Association, D.-T. F. (2013). Diagnostic and statistical manual of mental disorders: DSM-5™ (5th ed.). Arlington, VA, USA: American Psychiatric Publishing, Inc.
-
- Ashare, R. L., Norris, C. J., Wileyto, E. P., Cacioppo, J. T., & Strasser, A. A. (2013). Individual differences in positivity offset and negativity bias: Gender-specific associations with two serotonin receptor genes. Personality and Individual Differences, 55(5), 469–473. doi: 10.1016/j.paid.2013.04.009 - DOI - PMC - PubMed
-
- Bleuler, E. (1911). Dementia Praecox or the group of schizophrenias. New York: International Universities Press Inc.
-
- Bradley, M. M., & Lang, P. J. (2007). Emotion and motivation. In J. T. Cacioppo, L. G. Tassinary, & G. G. Berntson (Eds.), Handbook of psychophysiology (3rd ed., pp. 581–607). New York, NY, USA: Cambridge University Press.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials